ELI LILLY & Co — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-11-04

Reporting Person: LILLY ENDOWMENT INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	S	34941	$266.292	Disposed	108013669	Direct
2021-11-04	Common Stock	S	25227	$267.426	Disposed	107988442	Direct
2021-11-04	Common Stock	S	16469	$268.344	Disposed	107971973	Direct
2021-11-04	Common Stock	S	74067	$269.591	Disposed	107897906	Direct
2021-11-04	Common Stock	S	44240	$270.482	Disposed	107853666	Direct
2021-11-04	Common Stock	S	56	$271.00	Disposed	107853610	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.9887, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.99, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.99, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.98, inclusive.